| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417349 Water-soluble extract of asiaticoside and madecassoside from Centella asiatica and isolating method thereof |
| 07/09/2002 | US6417342 Isolated nucleic acids |
| 07/09/2002 | US6417327 Peptide capable of regulating physiological function of FGF-5 and pharmaceutical composition containing the peptide |
| 07/09/2002 | US6417234 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 07/09/2002 | US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis |
| 07/09/2002 | US6417229 Enzyme inhibitors |
| 07/09/2002 | US6417226 Contain alph-hydroxytetronic acid or a derivative, and, in some cases, hydroquinone, an alpha -hydroxy acid such as glycolic acid, and a fatty acid ester of ascorbic acid such as ascorbyl palmitate. |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417221 Tropane analogs and methods for inhibition of monoamine transport |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417217 Prolines as antimicrobial agents |
| 07/09/2002 | US6417215 Calcilytic compounds |
| 07/09/2002 | US6417214 Compounds as contraceptives |
| 07/09/2002 | US6417212 Modulators of peroxisome proliferator activated receptors |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417199 3-benzyl-benzothiophenes |
| 07/09/2002 | US6417196 Stabilization of quinapril using magnesium oxide |
| 07/09/2002 | US6417193 Methods for inhibiting MRP1 |
| 07/09/2002 | US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/09/2002 | US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
| 07/09/2002 | US6417183 1,4-diazacycloheptane derivatives |
| 07/09/2002 | US6417174 Inhibitors of β-lactamases and uses therefor |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416972 Purified hybrid nucleic acid |
| 07/09/2002 | US6416808 Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
| 07/09/2002 | US6416780 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them |
| 07/09/2002 | CA2211444C New benzimidazol, benzoxazol and benzothiazol derivitives, the procedure for preparing them and the pharmaceutical compositions which contain them. |
| 07/09/2002 | CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/04/2002 | WO2002052036A2 Identification of modulators of dham-kinase and inflammatory diseases |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051988A2 Thymic epithelial progenitor cells and uses thereof |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051855A2 Motilide compounds |
| 07/04/2002 | WO2002051849A1 Cdk4 inhibitors |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051847A1 Processes for preparing calanolide a and intermediates thereof |
| 07/04/2002 | WO2002051844A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 07/04/2002 | WO2002051843A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | WO2002051842A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051840A1 Method for producing the anticholinergic agent tiotropium bromide |
| 07/04/2002 | WO2002051838A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/04/2002 | WO2002051837A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051832A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | WO2002051828A2 Novel c-glycoside derivatives and use thereof |
| 07/04/2002 | WO2002051824A1 Amidinophenylalanine derivatives as thrombin inhibitors |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051810A2 Integrin receptor ligands |
| 07/04/2002 | WO2002051808A2 Muscarinic antagonists |
| 07/04/2002 | WO2002051806A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | WO2002051804A1 Crystalline forms of atorvastatin |
| 07/04/2002 | WO2002051799A1 Biphenyl derivatives |
| 07/04/2002 | WO2002051796A1 Amide derivatives |
| 07/04/2002 | WO2002051444A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051441A1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 07/04/2002 | WO2002051440A1 Combination drugs |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051429A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
| 07/04/2002 | WO2002051424A1 Drugs against articular failure |
| 07/04/2002 | WO2002051418A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 07/04/2002 | WO2002051415A2 Use of sequestrants for treating prion diseases |
| 07/04/2002 | WO2002051407A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 07/04/2002 | WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | WO2002051232A2 Novel benzazepines and related heterocyclic derivatives |
| 07/04/2002 | WO2002038543A3 3-substituted oxindole beta 3 agonists |
| 07/04/2002 | WO2002036556A3 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002022576A3 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors |
| 07/04/2002 | WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 07/04/2002 | WO2002003991A3 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001078779A3 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 07/04/2002 | WO2001078711A3 Pde-v inhibitors for treatment of parkinson's disease |
| 07/04/2002 | WO2001077097A3 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 07/04/2002 | WO2001062257A3 Bupropion metabolites and methods of their synthesis and use |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | WO2001041791A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/04/2002 | WO2001041535A9 Eplerenone crystalline form |